1 – 10 of 21
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Improving human papillomavirus (HPV) testing in the cervical cancer elimination era : The 2021 HPV LabNet international proficiency study
(
- Contribution to journal › Article
- 2021
-
Mark
Dynamics of IgG-avidity and antibody levels after Covid-19
(
- Contribution to journal › Article
-
Mark
The 2019 HPV Labnet international proficiency study : Need of global Human Papillomavirus Proficiency Testing
(
- Contribution to journal › Article
- 2018
-
Mark
Self-sampling with HPV mRNA analyses from vagina and urine compared with cervical samples
(
- Contribution to journal › Article
-
Mark
Continuing global improvement in human papillomavirus DNA genotyping services : The 2013 and 2014 HPV LabNet international proficiency studies
(
- Contribution to journal › Article
-
Mark
Clinical significance of IgM and IgA class anti-NMDAR antibodies in herpes simplex encephalitis
(
- Contribution to journal › Article
- 2017
-
Mark
Spectrum of HPV types before and after treatment of cervical intraepithelial neoplasia grade 2 and 3
(
- Contribution to journal › Article
- 2016
-
Mark
Effectiveness of HPV vaccination in women reaching screening age in Italy
(
- Contribution to journal › Article
- 2015
-
Mark
Evaluation of human papillomavirus DNA detection in samples obtained for routine Chlamydia trachomatis screening.
(
- Contribution to journal › Article
- 2013
-
Mark
Serum antibodies to human papillomavirus (HPV) pseudovirions correlate with natural infection for 13 genital HPV types.
(
- Contribution to journal › Article